Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Lucira Health, Inc. (LHDX)
|
Add to portfolio |
|
|
|
| Price: |
$7.67
| | Metrics |
| OS: |
40.6
|
M
| |
-431
|
% ROE
|
| Market cap: |
$311
|
M
| |
-381
|
% ROIC
|
|
Net cash:
|
$39.8
|
M
| |
$0.98
|
per share
|
|
EV:
|
$272
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($262)
|
M
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 93.1 | 0.3 | 11.4 | 8.0 |
| Revenue growth | 34492.9% | -97.6% | 42.6% | |
| Cost of goods sold | 81.4 | 1.9 | 11.4 | 8.0 |
| Gross profit | 11.7 | -1.7 | 0.0 | 0.0 |
| Gross margin | 12.5% | -621.6% | 0.0% | 0.0% |
| Selling, general and administrative | 35.5 | 5.6 | 2.4 | 1.8 |
| Research and development | 39.8 | 24.6 | | |
| EBIT | -63.7 | -31.9 | -13.9 | -9.8 |
| EBIT margin | -68.5% | -11868.0% | -121.2% | -122.4% |
| Pre-tax income | -64.8 | -37.3 | -8.5 | -6.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% |
| Net income | -64.8 | -37.3 | -8.5 | -6.5 |
| Net margin | -69.7% | -13884.0% | -74.0% | -81.5% |
| |
| Diluted EPS | ($1.86) | ($15.58) | ($4.04) | ($0.74) |
| Shares outstanding (diluted) | 34.8 | 2.4 | 2.1 | 8.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|